ESC Professional Premium Access

Valve disease in cardiac amyloidosis: an echocardiographic score

Topic: Infiltrative Myocardial Disease

Congress Presentation

About the speaker

Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)
4 presentations
0 follower

6 more presentations in this session

Incidence and factors associated with de novo atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis

Speaker: Doctor C. Fumagalli (Florence, IT)


Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a single center experience

Speaker: Doctor L. Scudeler (Turin, IT)


NNC6019-0001, a humanized monoclonal antibody, in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): rationale and study design of a phase 2, randomized, placebo-controlled trial

Speaker: Professor M. Fontana (London, GB)


Change in echocardiography in patients with transthyretin amyloid cardiomyopathy with tafamidis treatment.

Speaker: Doctor M. Morioka (Kumamoto, JP)


Global longitudinal strain and quantitative sensory testing in pre-symptomatic patients with mutation for transthyretin amyloidosis

Speaker: Associate Professor M. Losi (Naples, IT)


Access the full session

Amyloidosis and aortic stenosis

Speakers: Doctor A. Aimo, Doctor C. Fumagalli, Doctor L. Scudeler, Professor M. Fontana, Doctor M. Morioka...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb